SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition

Kim, Eunhee, Ilagan, Janine O., Liang, Yang, Daubner, Gerrit M., Lee, Stanley C.-W., Ramakrishnan, Aravind, Li, Yue, Chung, Young Rock +17 more·2015·Cancer Cell
DOI 10.1016/j.ccell.2015.04.006

Cited by (582)

Items 501–582 of 582

  1. The human branchpoint-interacting stem loop sequence and structure regulates U2 snRNA expression, branchpoint recognition, and transcriptome
    Meredith Stevers, Sol J. Katzman, Melissa S. Jurica · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  2. RNA splicing factor mutations drive myeloid neoplasm oncogenesis through protein complex poisoning
    Pedro Luís Moura, Rui Mamede Branca, Yaroslav Kaminskiy, Ioannis Siavelis, Kovi R Shrung, Sophia Hofmann, Christina Maria Perraki, Alexandra Argyriou, Sadaf Fazeli, Masahiro M Nakagawa et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  3. Identification of common and distinct epigenetic re-programming properties of Core-Binding Factor (CBF) Fusion Proteins
    Justin Ching Ting Loke, Anetta Ptasinska, Maria Rosaria Imperato, Salam Adli Assi, Pierre Cauchy, Ian G. Cowell, Olaf T Heidenreich, Manoj Raghavan, Ruud Delwel, PN Cockerill et al. · 2016 · Klinische Pädiatrie
  4. Large-scale study of rna processing alterations in multiple cancers
    Babita Singh · 2017 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
  5. Mutant P53 in pre-leukemic hematopoietic stem cells and the pathogenesis of Myelodysplastic Syndrome
    Sisi Chen · 2018 · IUScholarWorks (Indiana University)
  6. Impaired hematopoiesis and leukemia development in mice with a conditional “knock-in” allele of a mutant splicing factor gene U2af1
    Dennis Liang Fei, Tao Zhen, Benjamin Durham, John Ferrarone, Tuo Zhang, Lisa Garrett, Akihide Yoshimi, Omar Abdel-Wahab, Robert K. Bradley, Paul Liu et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  7. Genetics, prognosis, and transplantation for myelofibrosis
    H. Joachim Deeg, Rachel B. Salit, Bart Lee Scott, Janghee Woo · 2018 · Advances in Cell and Gene Therapy
  8. Molecular Genetics in Myelodysplasia Outcomes Prognostication
    Lucas H. Rifkin, Eric Y. Loo · 2019 · Advances in Molecular Pathology
  9. Are all splicing mutations the same?
    Teresa Venezia Bowman, Charles C. Query · 2020 · Blood
  10. [Research progress on clonal acquired sideroblastic anemia].
    Z B Long, Y L Du, B Han · 2017 · PubMed Central
  11. Mutations in the Spliceosomal Gene ZRSR2 in Myelodysplastic Syndromes
    Harold Phillip Koeffler · 2019
  12. Molecular Landscape of MDS
    Torsten Haferlach, Ines Schmidts · 2020 · Springer eBooks
  13. FDA classification of sterilization wraps.
    N E Danielson · 1981 · PubMed
  14. Entrevista a Jesús Rodríguez Cortezo
    Jesús Rodríguez Cortezo · 2009 · El Instalador
  15. Rock inhibitors target SRSF2 leukemia by disrupting cell mitosis and nuclear morphology
    M Su, Thomas A. Fleisher, Inna Grosheva, Melanie Bokstad Horev, Malgorzata Olszewska, Haim Michael Barr, Alexander N. Plotnikov, Sílvia Carvalho, Yoni Moskovich, MD Minden et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  16. Chemokine Receptor 1 and its associated immune pathway are downregulated in SF3B1 MT blood and non-blood cancers
    Mahtab Dastpak, Hyunmin Kim, Christina L. Paraggio, Claudia E. Leonard, Shanye Yin, Binkai Chi, Kelsey W. Nassar, R. Grant Rowe, Zhonggang Hou, Jiuchun Zhang et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  17. Splicing role of PRPF40A/B paralogs in human myeloid cells
    Cheryl Weiqi Tan · 2021
  18. 18. Molecular Pathogenesis and Treatment of Myelodysplastic Syndromes
    Hideaki Nakajima · 2020 · Nihon Naika Gakkai Zasshi
  19. Faculty Opinions recommendation of U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignancies.
    Stephen D. Nimer, Glòria Mas Martín · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  20. Faculty Opinions recommendation of PRMT5 Regulates DNA Repair by Controlling the Alternative Splicing of Histone-Modifying Enzymes.
    Scott A. Ness · 2018 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  21. Faculty Opinions recommendation of Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis.
    Housheng Hansen He · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  22. Advances in the Study of High-Risk Gene Mutations for Primary Myelofibrosis
    Shaoming Xu, Youshan Zhang, Jie Tan, Caixia Liang · 2022 · Journal of Biosciences and Medicines
  23. Molecular Threat of Splicing Factor Mutations to Myeloid Malignancies and Potential Therapeutic Modulations
    Fangliang Zhang, Liang Chen · 2022 · Biomedicines
  24. Reclassification of Splicing Gene Variants in Hereditary Cancer: Cases Report and Literature Review
    Dimitra Bouzarelou, Κωνσταντίνος Αγιαννιτόπουλος, Georgios Tsaousis, Eirini Papadopoulou, George Nasioulas · 2023 · In Vivo
  25. 1399 Identification of alternative splicing-derived targets for TCR-T cell therapies
    Elise C. Wilcox, Alex Chen, Chenwei Lin, Lisa A Jones, Philip R. Gafken, Roland K. Strong, Stanley Chun-Wei Lee, Aude G. Chapuis · 2023 · Regular and Young Investigator Award Abstracts
  26. The Origin of Clonal Hematopoiesis and Its Implication in Human Diseases
    Zhen Zhang, Jianlong Sun · 2023 · Advances in experimental medicine and biology
  27. Genetic associations with human longevity are enriched for oncogenic genes
    Jun Young Park, Andrés Peña‐Tauber, Lia Talozzi, Michael D. Greicius, Yann Le Guen · 2024 · medRxiv
  28. Unsupervised reference-free inference reveals unrecognized regulated transcriptomic complexity in human single cells
    Roozbeh Dehghannasiri, George Henderson, Rob Bierman, Tavor Z. Baharav, Kaitlin Chaung, Peter Lincoln Wang, Julia Salzman · 2025 · eLife
  29. Unsupervised reference-free inference reveals unrecognized regulated transcriptomic complexity in human single cells
    Roozbeh Dehghannasiri, George Henderson, Rob Bierman, Tavor Z. Baharav, Kaitlin Chaung, Peter Lincoln Wang, Julia Salzman · 2025 · eLife
  30. Sensitivity to ATR–CHK1 pathway inhibition in AML/MDS is enhanced by SRSF2 mutations and reduced by RUNX1 loss
    Samuli Eldfors, Sumit Rai, Vineet Sharma, Tareq Hossan, Claudia C. Pastrana, Amy M. Bertino, Angelique Gilbert, Kimmo Porkka, Matthew J. Walter, Timothy Aaron Graubert · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  31. A Unifying Mechanism for Shared Splicing Aberrations in Splicing Factor Mutant Cancers
    Prajwal Chaitanya Boddu, Rahul Roy, Stephan Hütter, Francis Baumgartner, Wenxue Li, Gabriele Todisco, Francesca Ficara, Matteo Giovanni Della Porta, Yansheng Liu, Torsten Haferlach et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  32. Prpf4 sequentially regulates the expansion and maturation of erythrocyte through distinct mechanisms
    Zhilin Deng, Shuying Huang, Yu Pei, Hanxiang Li, Yong Dong, Yuanyuan Li, Qin Ran, Xindong Liu, Yi Feng, Qiang Wang et al. · 2025 · Cell Death Discovery
  33. Additional file 2 of Mutational landscape of chronic myelomonocytic leukemia in Chinese patients
    Nie, Yanbo, Liang Shao, Zhang, Hong, Colin K. He, Li, Hongyu, Junyan Zou, Chen, Long, Huaiyue Ji, Hao Tan, Lin, Yani et al. · 2022 · Figshare
  34. Additional file 5 of Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer
    Chiara Naro, Ambra Antonioni, Vanessa Medici, Cinzia Caggiano, Ariane Jolly, Pierre de la Grange, Pamela Bielli, Maria Paola Paronetto, Claudio Sette · 2024 · Figshare
  35. Additional file 2 of RBM10 C761Y mutation induced oncogenic ASPM isoforms and regulated β-catenin signaling in cholangiocarcinoma
    Jiang Chang, Zhang, Yaodong, Zhou, Tao, Qiao, Qian, Shan, Jijun, Yananlan Chen, Wangjie Jiang, Wang, Yirui, Liu, Shuochen, Wang, Yuming et al. · 2024 · Figshare
  36. Additional file 3 of Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer
    Chiara Naro, Ambra Antonioni, Vanessa Medici, Cinzia Caggiano, Ariane Jolly, Pierre de la Grange, Pamela Bielli, Maria Paola Paronetto, Claudio Sette · 2024 · Figshare
  37. Additional file 5 of RBM10 C761Y mutation induced oncogenic ASPM isoforms and regulated β-catenin signaling in cholangiocarcinoma
    Jiang Chang, Zhang, Yaodong, Tao Zhou, Qiao, Qian, Shan, Jijun, Yananlan Chen, Wangjie Jiang, Wang, Yirui, Liu, Shuochen, Wang, Yuming et al. · 2024 · Figshare
  38. Additional file 1 of Mutational landscape of chronic myelomonocytic leukemia in Chinese patients
    Nie, Yanbo, Liang Shao, Zhang, Hong, Colin K. He, Li, Hongyu, Zou, Junyan, Chen, Long, Huaiyue Ji, Hao Tan, Yani Lin et al. · 2022 · Figshare
  39. Additional file 4 of Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer
    Chiara Naro, Ambra Antonioni, Vanessa Medici, Cinzia Caggiano, Ariane Jolly, Pierre de la Grange, Pamela Bielli, Maria Paola Paronetto, Claudio Sette · 2024 · Figshare
  40. Additional file 1 of Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer
    Chiara Naro, Ambra Antonioni, Vanessa Medici, Cinzia Caggiano, Ariane Jolly, Pierre de la Grange, Pamela Bielli, Maria Paola Paronetto, Claudio Sette · 2024 · Figshare
  41. Additional file 1 of RBM10 C761Y mutation induced oncogenic ASPM isoforms and regulated β-catenin signaling in cholangiocarcinoma
    Jiang Chang, Zhang, Yaodong, Zhou, Tao, Qiao, Qian, Shan, Jijun, Yananlan Chen, Wangjie Jiang, Wang, Yirui, Shuochen Liu, Wang, Yuming et al. · 2024 · Figshare
  42. Additional file 3 of RBM10 C761Y mutation induced oncogenic ASPM isoforms and regulated β-catenin signaling in cholangiocarcinoma
    Jiang Chang, Zhang, Yaodong, Zhou, Tao, Qiao, Qian, Jijun Shan, Yananlan Chen, Wangjie Jiang, Wang, Yirui, Liu, Shuochen, Wang, Yuming et al. · 2024 · Figshare
  43. Additional file 2 of Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer
    Chiara Naro, Ambra Antonioni, Vanessa Medici, Cinzia Caggiano, Ariane Jolly, Pierre de la Grange, Pamela Bielli, Maria Paola Paronetto, Claudio Sette · 2024 · Figshare
  44. Additional file 4 of RBM10 C761Y mutation induced oncogenic ASPM isoforms and regulated β-catenin signaling in cholangiocarcinoma
    Jiang Chang, Zhang, Yaodong, Tao Zhou, Qiao, Qian, Shan, Jijun, Yananlan Chen, Wangjie Jiang, Wang, Yirui, Liu, Shuochen, Wang, Yuming et al. · 2024 · Figshare
  45. Medicinal chemistry approaches to modulation of splicing, RNA modifications, and RNA editing in cancer therapeutics
    Hartmut Schirok, Lutz Lehmann, Hanna Torianyk, Nathalie Kary, Annita Louloupi, Razvan Nutiu, Yi‐Tao Yu, Pedro Morais · 2025 · Elsevier eBooks
  46. Clonal hematopoiesis is associated with future diseases and mortality
    Weishi Liu, Yueting Deng, Liu Yang, Ziyi Wang, Lingzhi Ma, Yuming Xu, Qiang Dong, Jianfeng Feng, Wei Cheng, Jintai Yu · 2025 · Chinese Medical Journal
  47. A Yeast-Based High-Throughput Screening Platform for the Discovery of Novel pre-mRNA Splicing Modulators
    Sierra L. Love, Henrik Vollmer, Ya‐Chu Chang, Joshua C. Paulson, Tucker J. Carrocci, Melissa S. Jurica, Hai Dang Nguyen, Aaron A. Hoskins · 2026 · ACS Chemical Biology
  48. SRSF2 mutations drive daunorubicin resistance in acute myeloid leukemia via THBS1 stabilization
    Ye Wu, Xia Wu, Yali Tang, Ying Zhang, Yiwen Du, Kun Yang, Yankun Yang, Yuping Gong · 2026 · Journal of Experimental & Clinical Cancer Research
  49. Role of alternative splicing in cancer progression
    Maryam Bashir, Muhammad Adnan Sabir Mughal, Faryal Ikram, Muhammad Kasib Khan, Zaheer Abbas, Muhammad Shahid Mehmood, Amna Sarwar, Mehroz Latif, Sultan Ali, Sundas Afresham · 2026 · Irish Journal of Medical Science (1971 -)
  50. The human branchpoint-interacting stem-loop sequence and structure regulates U2 snRNA expression, branchpoint recognition, and the transcriptome
    Meredith Stevers, Sol J. Katzman, Melissa S. Jurica · 2026 · Nucleic Acids Research
  51. Site-specific methylation of SRSF2 P95H by SETD2 inhibits MDSC-mediated proinflammatory niche formation in mouse models of myelodysplastic syndrome
    Zi-Juan Li, Mu-ying Zhao, Roujia Wang, Na Liu, Cheng-Long Hu, Binhe Chang, Fang Hu, Xi-Ya Li, Chunhui Xu, Ping Liu et al. · 2026 · Science Translational Medicine
  52. Etude des altérations génomiques acquises dans les leucémies aiguës myéloïdes impliquant le core binding factor
    Nicolas Duployez · 2017
  53. Genetics of Ocular Melanomas
    Manuel Jorge Rodrigues · 2018
  54. Génétique et architecture clonale des leucémies myélomonocytaires juvéniles sporadiques et syndromiques
    Aurélie Caye‐Eude · 2018
  55. Développement de stratégies de criblage de mutations d'épissage dans des gènes de prédisposition au cancer.
    Hélène Tubeuf · 2019 · theses.fr (ABES)
  56. Regulation of alternative splicing and polyadenylation by genotoxic anti-cancer agents
    Iris Tanaka · 2019 · theses.fr (ABES)
  57. The role of histone modifications in the regulation of alternative splicing during epithelial-to-mesenchymal transition
    Alexandre Segelle · 2020 · theses.fr (ABES)
  58. Role of SF3B1 Mutations in Uveal Melanoma Oncogenesis
    Raquel Vivet-Noguer · 2021 · theses.fr (ABES)
  59. Identifier et exploiter de nouvelles vulnérabilités à potentiel thérapeutique dans les leucémies aiguës myéloïdes
    Camille Vaganay · 2023
  60. Structural characterization of RNA binding to RNA recognition motif (RRM) domains using data integration, 3D modeling and molecular dynamic simulation
    Hrishikesh Dhondge · 2023
  61. Étude de la restauration de la réponse immunitaire antitumorale dans un modèle murin de cancer pulmonaire induit par une molécule multicible inhibitrice de HDAC et du splicéosome
    Sarah Ducellier · 2023
  62. Inflammation et hématopoïèse – Rôles de la Calprotectine et de la protéine IGFBP2 (Insulin like Growth Factor Binding Protein 2)
    Valentine Marchand · 2024 · theses.fr (ABES)
  63. Modeling Chronic Myelomonocytic Leukemia with the Aim of Identifying Novel Therapeutic Targets
    Dana Alawieh · 2025 · theses.fr (ABES)
  64. RNA-binding proteins activate transcription through defined molecular grammars
    Haoran Wang, Lydia Phillips, Dervla Moore-Frederick, Bailey K. Webster, Deyuan Xu, Sid Srivastava, Grant Mowry, Emily Wang, Arth Banka, Changfeng Deng et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  65. Small-Molecule-Directed RNA Modification via Proximity-Driven Catalysis
    Song Chen, Tuan‐Khoa Kha, Yiran Zhao, Junsong Guo, Baixi CHEN, Ru‐Yi Zhu · 2026 · Journal of the American Chemical Society
  66. A U1–U3 snRNA–snoRNA interaction couples SF3B1 mutation to chromatin-state rewiring and genome instability
    Peng Xia, Han Li, Yiyi Ji, Cheng‐Wei Ju, Yiqian Pan, Jing Mo, Xuanhao Zhu, Lijie Zhao, Ruitu Lyu, Erica L. Niewold et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  67. Alternative splicing rewires breast cancer and opens therapeutic avenues
    Yuhan Jin, Yiran Liang, Mahsa Maghsoudy Kasvaei, Qifeng Yang · 2026 · Cell Communication and Signaling
  68. Inflammatory Signatures in MDS: The Missing Link Between Genetics, Microenvironment, and Therapy
    Adele Bottaro, Maria Elisa Nasso, Giuseppe Mirabile, Manlio Fazio, Alessandro Allegra · 2026 · Cells
  69. A phase 1b/2 study of ceralasertib, a selective inhibitor of ATR, in patients with relapsed or refractory MDS and CMML
    Andrew Mark Brunner, Yiwen Liu, Jacqueline Suen Garcia, Lourdes Mendez, Catherine Gutierrez, Sridhar Nonavinkere Srivatsan, Jin Shao, Brandon J. Aubrey, Philip C. Amrein, Rupa Narayan et al. · 2026 · Blood Advances
  70. Targeting the 3’ splice site by a decoy oligonucleotide attenuates U2AF1 splicing activity and inhibits leukemia
    Carla Azar-Koussa, Marina Sakran, Efraim Rahamim, Anurag V Prabhu, Samar Salem, Adina R. Heinberg, Zahava Siegfried, Meital Ben-David-Naim, Eran Zimran, Erez Y. Levanon et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  71. Splicing Factor Mutations in Clonal Hematopoiesis and Progression to Myeloid Neoplasms
    Yang Lyu, Yutong Zhang, Ayana Kon · 2026 · Cancer Science
  72. Epigenetic alterations in Myeloid Malignancies
    Bruno António Cardoso · 2026 · Advances in experimental medicine and biology
  73. PANoptosis in the pathogenesis of myelodysplastic syndromes
    Rohit Thalla, Jyoti Lamichhane, Cameron Lewis, Peter Breslin, Jiwang Zhang · 2026 · Molecular Oncology
  74. Targeting SRPK3 Attenuates Cardiac Hypertrophy and Heart Failure by Improving Mitochondrial Bioenergetics through mRNA Splicing and Decay
    Yunting Zhan, Gao-Yuan Liang, Jie Wang, Xian-Feng Cen, Nan Zhang, Nan Zhao, Yun Xing, Lan-lan Li, Tianhang Yu, Wen-Sheng Dong et al. · 2026 · Research
  75. CRISPR-mediated Correction of Oncogenic AS-NMD in Splicing Factor Mutant Cancer
    Preeti Nagar, Md Rafikul Islam, Nirjhor Anuvob Rahman, Shabiha Afroj Heeamoni, Md Mahbub Hasan, Saaimatul Huq, Rezwan Ali, Mokarram Hossain, Mohammad Alinoor Rahman · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  76. Targeting splicing-derived neoantigens for precision cancer immunotherapy
    Mutian Tang, H. Leighton Grimes, Nathan Salomonis · 2026 · Frontiers in Immunology
  77. SRSF2 P95H induces monocytic priming of human hematopoietic stem and progenitor cells
    Johannes Foßelteder, Gabriel Pabst, Andrea Raicht, Tommaso Sconocchia, Angelika Schlacher, Lisa Auinger, Daniel Martinez-Krams, Asiri Ediriwickrema, Katarina Vizar Cisarova, Peter Schlenke et al. · 2026 · Leukemia
  78. NUDT21 Promotes Myelodysplastic Syndrome Progression by Regulating SRSF2 Expression via Alternative Polyadenylation
    Dongmei Guan, Wenjie Xu, Shuo Li, Peichun Li, Jiakai Bian, Hongwei Wang, 任方刚 · 2026 · Hematological Oncology
  79. Sensitivity to ATR–CHK1 pathway inhibition in MDS/AML is enhanced by SRSF2 mutations and reduced by RUNX1 loss
    Samuli Eldfors, Sumit Rai, Vineet Sharma, Tareq Hossan, Claudia C. Pastrana, Amy M. Bertino, Angelique Gilbert, Sridhar Nonavinkere Srivatsan, Kimmo Porkka, Matthew J. Walter et al. · 2026 · Leukemia
  80. ZC3H14 phosphorylation is required for nuclear speckle assembly during zygotic splicing activation in mice
    Yang Wang, Hua Zhang, Zhe-Wei Hu, Dan Su, Jing Zhao, Xiaoying Fan, Liling Liu, Heng‐Yu Fan · 2026 · EMBO Reports
  81. The Spliceosome Scaffold Component BCAS2 Promotes Pancreatic Cancer Progression through Weak 5′ Splice Site–Dependent Splicing Regulation
    Ledong Wan, Mei Wang, Yuma Ishigami, Alexander J. Kral, Kuan-Ting Lin, Joseph R. Merrill, Scott K. Lyons, Adrian R. Krainer · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  82. CRISPR-mediated correction of oncogenic AS-NMD in splicing factor mutant cancer
    Preeti Nagar, Md Rafikul Islam, Nirjhor Anuvob Rahman, Shabiha Afroj Heeamoni, Md Mahbub Hasan, Saaimatul Huq, Fariha Alam Bushra, Mengye Hu, Rezwan Ali, Mokarram Hossain et al. · 2026 · Frontiers in Immunology